Pre-Market Health Care Stocks Analysis: Medtronic, Abbott Laboratories, Hologic, and ArthroCare

   Pre-Market Health Care Stocks Analysis: Medtronic, Abbott Laboratories,
                           Hologic, and ArthroCare

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

LONDON, March 13, 2014

LONDON, March 13, 2014 /PRNewswire/ --

On Wednesday, March 12, 2014, the NASDAQ Composite ended at 4,323.33, up
0.37%, the Dow Jones Industrial Average fell 0.07% to 16,340.08, and the S&P
500 closed at 1,868.20, up 0.03%. The gains were narrow based as four out of
ten sectors ended the session in positive. The S&P 500 Health Care Sector
Index finished the day at 687.90, down 0.01%, while the same has gained 3.36%
in the last one month. Investor-Edge.com has initiated coverage on the
following equities: Medtronic Inc. (NYSE: MDT), Abbott Laboratories (NYSE:
ABT), Hologic Inc. (NASDAQ: HOLX), and ArthroCare Corporation (NASDAQ: ARTC).
Free research on these four companies can be accessed at: 

http://investor-edge.com/register

Medtronic Inc.'s stock closed at $59.83 on Wednesday, which is 0.71% lower
than the previous day's closing price of $60.26. A total of 4.26 million
shares were traded, which is below the three months average volumes of 4.99
million. The company's shares oscillated between $59.64 and $60.24 during the
trading session. Medtronic Inc.'s shares have advanced 6.03% in the last one
month and 7.51% in the previous three months. The stock is trading at a PE
ratio of 16.23 and has gone up 4.25% on YTD basis. The stock is trading above
its 50-day and 200-day moving averages. The company's 50-day moving average of
$57.86 is above the 200-day moving average of $55.46. Furthermore, the stock
is trading at the Relative Strength Index (RSI) of 70.57. Sign up and read the
free notes on MDT at:

http://www.Investor-Edge.com/03132014/MDT/report.pdf

Shares in Abbott Laboratories witnessed trading of 6.93 million shares on
Wednesday, as compared with a three month average volume of 7.71 million
shares. The stock ended the day at $39.66, down 0.13% and at an intraday
trading range of $39.44 and $39.89 during the session. The stock traded at a
PE ratio of 21.09. Shares in Abbott Laboratories have gained 3.66% in the last
one month, 9.29% in the previous three months and 3.47% on YTD basis. The
stock is trading above its 50-day and 200-day moving averages. The company's
50-day moving average of $38.44 is above the 200-day moving average of $36.63.
Additionally, shares of the company are trading at the Relative Strength Index
(RSI) of 60.52. The complimentary notes on ABT can be downloaded as in PDF
format at:

http://www.Investor-Edge.com/03132014/ABT/report.pdf

On Wednesday, Hologic Inc.'s stock declined 0.47% finishing the session at
$22.11. The stock recorded a trading volume of 2.02 million shares as compared
to a three months average volume of 2.62 million shares. The company's shares
fluctuated between $21.96 and $22.29 during the session. Hologic Inc.'s shares
have advanced 3.27% in the last one month and 2.12% in the previous three
months while the same has fallen by 1.07% on YTD basis. The stock is trading
above its 50-day and 200-day moving averages. Hologic Inc.'s 50-day moving
average of $21.67 is above the 200-day moving average of $21.52. Moreover,
shares of the company are trading at the Relative Strength Index (RSI) of
58.73. Register for free on Investor-Edge and access the latest research on
HOLX at:

http://www.Investor-Edge.com/03132014/HOLX/report.pdf

Shares in ArthroCare Corp. recorded a trading volume of 0.30 million shares,
as compared with a three month average volume of 0.54 million shares. The
stock ended Wednesday's session at $48.15, down 0.06% after vacillating
between $48.13 and $48.24. Shares in ArthroCare Corp. have surged 24.13% in
the previous three months and 19.66% on YTD basis. The company's shares are
trading at a PE ratio of 31.80 and above its 50-day and 200-day moving
averages. ArthroCare Corp.'s 50-day moving average of $46.78 is above the
200-day moving average of $38.45. Furthermore, the stock is trading at the
Relative Strength Index (RSI) of 55.75. The complete research on ARTC is
available for free at:

http://www.Investor-Edge.com/03132014/ARTC/report.pdf

About Investor-Edge.com

At Investor-Edge, we provide our members with a simple and reliable way to
leverage our economy of scale. Most investors do not have time to track all
publicly traded companies, much less perform an in-depth review and analysis
of the complexities contained in each situation. That's where Investor-Edge
comes in. We provide a single unified platform for investors' to hear about
what matters. Situation alerts, moving events, and upcoming opportunities.

=============

EDITOR NOTES:

=============

  oThis is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
  oInformation in this release is fact checked and produced on a best efforts
    basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
  oThis information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
  oIf you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at pubco [at]
    Investor-edge.com.
  oFor any urgent concerns or inquiries, please contact us at compliance [at]
    Investor-edge.com.
  oAre you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to research [at]
    Investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Investor-edge. An
outsourced research services provider represented by Nidhi Vatsal, CFA, has
only reviewed the information provided by Investor-edge in this article or
report according to the Procedures outlined by Investor-edge. Investor-edge is
not entitled to veto or interfere in the application of such procedures by the
outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-edge makes no warranty, expressed or implied, as to the accuracy or
completeness or fitness for a purpose (investment or otherwise), of the
information provided in this document. This information is not to be construed
as personal financial advice. Readers are encouraged to consult their personal
financial advisor before making any decisions to buy, sell or hold any
securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-edge is not responsible for any error which may be occasioned at the
time of printing of this document or any error, mistake or shortcoming. No
liability is accepted by Investor-edge whatsoever for any direct, indirect or
consequential loss arising from the use of this document. Investor-edge
expressly disclaims any fiduciary responsibility or liability for any
consequences, financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee the
accuracy, timeliness, completeness or correct sequencing of the information,
or (2) warrant any results from use of the information. The included
information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

Investor-Edge.com

SOURCE Investor-Edge

Contact: Adam Redford, +852-8191-3972
 
Press spacebar to pause and continue. Press esc to stop.